Type 2 diabetes patients often have endogenous hyperinsulinemia due to insulin resistance, while type 1 diabetes patients often experience hyperinsulinemia due to exogenous insulin therapy even though they do not secrete insulin endogenously. The gene discussed is INS; the disease is type 2 diabetes mellitus.